Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft
NCT: NCT07574411 · NOT_YET_RECRUITING
Brief Summary
Coronary artery disease (CAD) is a heart disease caused by the buildup of plaque inside the coronary arteries that restricts blood flow to the heart which leads to heart attack. If it involve more than one artery it will be more critical so the preferred treatment will be coronary artery bypass graft. Respiratory failure after Coronary Artery Bypass Grafting (CABG) is a serious complication with multifactorial causes i.e. pneumonia and atelectasis in inpatients. Postoperative pulmonary complications will be diagnosed using the Melbourne Group Scale (MGS), applied daily from postoperative day 1 to day 7. A score of ≥4 positive criteria will be used to identify PPCs. The scale's criteria will include chest radiograph findings, oxygen saturation, sputum characteristics, inflammatory markers, and ventilation data, physician diagnosis of pneumonia, readmission to ICU for respiratory reasons, prolong ventilation\> 24 hours, unplanned use of non-invasive ventilation.
Frequently Asked Questions
What is Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft?
Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft is a clinical trial registered under NCT07574411. Current status: NOT_YET_RECRUITING.
What is the status of NCT07574411?
The current status of NCT07574411 (Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft) is: NOT_YET_RECRUITING.
When did Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft start?
Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft started on 2026-05-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.